These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 8001943)

  • 61. Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.
    Balogun MA; Murphy N; Nunn S; Grant A; Andrews NJ; Teo CG; Ramsay ME; Parry JV
    Epidemiol Infect; 2009 Jul; 137(7):980-7. PubMed ID: 19102796
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
    Taylor A; Goldberg D; Hutchinson S; Cameron S; Gore SM; McMenamin J; Green S; Pithie A; Fox R
    J Infect; 2000 Mar; 40(2):176-83. PubMed ID: 10841096
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methadone maintenance and hepatitis C virus infection among injecting drug users.
    Crofts N; Nigro L; Oman K; Stevenson E; Sherman J
    Addiction; 1997 Aug; 92(8):999-1005. PubMed ID: 9376782
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
    van Beek I; Chronister KJ
    Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users.
    Robinson GM; Reynolds JN; Robinson BJ
    N Z Med J; 1995 Mar; 108(996):103-5. PubMed ID: 7715873
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Prevalence of HIV and HCV among injecting drug users (IDUs) in Yunnan, China].
    Li D; Zheng X; Zhang G
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):74-5. PubMed ID: 7522968
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
    J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users.
    Kato H; Maeno Y; Seko-Nakamura Y; Monma-Ohtaki J; Sugiura S; Takahashi K; Zhe LX; Matsumoto T; Kurvanov F; Mizokami M; Nagao M
    Forensic Sci Int; 2007 May; 168(1):27-33. PubMed ID: 16829004
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia.
    Medić A; Dzelalija B; Sonicki Z; Zekanović D
    Coll Antropol; 2008 Sep; 32(3):697-702. PubMed ID: 18982740
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
    Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
    Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence and risk factors of hepatitis C in HIV-negative homosexual men in Sydney, Australia.
    Jin F; Prestage GP; Kippax SC; Kaldor JM; Dore GJ; Grulich AE
    Aust N Z J Public Health; 2005 Dec; 29(6):536-9. PubMed ID: 16370051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs.
    Buffington J; Murray PJ; Schlanger K; Shih L; Badsgard T; Hennessy RR; Wood R; Weisfuse IB; Gunn RA
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):63-7. PubMed ID: 17542456
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
    Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
    Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales.
    Craine N; Walker AM; Williamson S; Brown A; Hope VD
    Commun Dis Public Health; 2004 Sep; 7(3):216-9. PubMed ID: 15481216
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia].
    Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Indications of immune protection from hepatitis C infection.
    Aitken CK; Bowden S; Hellard M; Crofts N
    J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.
    Garfein RS; Doherty MC; Monterroso ER; Thomas DL; Nelson KE; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S11-9. PubMed ID: 9663618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.